newsfilter
← Latest News
GlobeNewswire·

Emergent BioSolutions Reports First Quarter 2026 Financial Results

First Quarter 2026 Total Revenues of $156.1 millionFirst Quarter 2026 Net Income of $6.8 million and Net Income Margin of 4%First Quarter 2026 Adjusted EBITDA of $35.6 million and Adjusted EBITDA Margin of 23%